Recombinant RSV (Palivizumab Biosimilar) antibody

Catalog No. ABIN7200664

The Humanized Monoclonal anti-RSV (Palivizumab Biosimilar) antibody (ABIN7200664) specifically detects RSV (Palivizumab Biosimilar) in FACS and in vivo. The antibody is reactive with Human samples.

Quick Overview for Recombinant RSV (Palivizumab Biosimilar) antibody (ABIN7200664)

Target: RSV (Palivizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Monoclonal

Conjugate: This RSV (Palivizumab Biosimilar) antibody is un-conjugated

Application: Flow Cytometry (FACS), In vivo Studies (in vivo)

Grade: Research Grade

Product Details anti-RSV (Palivizumab Biosimilar) Antibody

Purpose: Palivizumab Biosimilar, RSV Monoclonal Antibody

Specificity: The monoclonal antibody palivizumab biosimilar specifically binds to an epitope in the A antigenic site of the F protein of RSV (respiratory syncytial virus).

Characteristics: Palivizumab, a humanized anti-RSV (respiratory syncytial virus) monoclonal antibody, targets an epitope in the A antigenic site of the F protein of RSV, inhibiting its entry into the cell and thereby preventing infection.

Purification: Protein A or G affinity column

Purity: >95 % by reducing SDS-PAGE

Sterility: 0.2 μm filtered

Endotoxin Level: < 1 EU per 1 mg of the protein by the LAL method

Immunogen: The monoclonal antibody palivizumab biosimilar was produced in the palivizumab biosimilar CHO stable cell line.

Isotype: IgG1

Application Details

Application Notes: ELISA, neutralization, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by palivizumab.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: > 3 mg/mL

Buffer: PBS, pH 7.4, no stabilizers or preservatives.

Preservative: Without preservative

Storage: 4°C,-20 °C

Storage Comment: 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.

Expiry Date: 12 months

Target Details for RSV (Palivizumab Biosimilar)

Target: RSV (Palivizumab Biosimilar)

Alternative Name: Palivizumab Biosimilar

Target Type: Biosimilar